Immuno Oncology Market by 2022- A Global Forecast
World’s one of the biggest and liable market research resource, Research and Markets recently published Immuno-Oncology Market, By Type and
Read moreamgen
Kyprolis for Combination use in Patients with Relapsed Multiple Myeloma Gets EC Approval
European Commission (EC) provided marketing authorization for Amgen’s Kyprolis® (carfilzomib) in combo with lenalidomide and dexamethasone for the therapy of
Read moreThe Morgan Stanley Global Healthcare Conference: Amgen’s presentation
THOUSAND OAKS, California: The Morgan Stanley Global Healthcare Conference scheduled for Tuesday, Sept. 13, 2011 at the Grand Hyatt in
Read moreAMGEN: Second Quarter of 2011 Witnessed a Revenue Hike of 4% to $4.0 Billion
Amgen’s second quarter product sales for 2011 saw a spike of 8% to $3.9 billion. The adjusted and GAAP Earnings
Read more